Home Cart 0 Sign in  
X

[ CAS No. 5198-86-7 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 5198-86-7
Chemical Structure| 5198-86-7
Chemical Structure| 5198-86-7
Structure of 5198-86-7 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 5198-86-7 ]

Related Doc. of [ 5198-86-7 ]

Alternatived Products of [ 5198-86-7 ]

Product Details of [ 5198-86-7 ]

CAS No. :5198-86-7 MDL No. :MFCD04115727
Formula : C4H4BrNOS Boiling Point : -
Linear Structure Formula :- InChI Key :FRPHIGOLOLSXAI-UHFFFAOYSA-N
M.W : 194.05 Pubchem ID :2763211
Synonyms :

Calculated chemistry of [ 5198-86-7 ]

Physicochemical Properties

Num. heavy atoms : 8
Num. arom. heavy atoms : 5
Fraction Csp3 : 0.25
Num. rotatable bonds : 1
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 35.94
TPSA : 61.36 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.68 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.56
Log Po/w (XLOGP3) : 1.13
Log Po/w (WLOGP) : 1.25
Log Po/w (MLOGP) : -0.01
Log Po/w (SILICOS-IT) : 2.69
Consensus Log Po/w : 1.32

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 2.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.15
Solubility : 1.37 mg/ml ; 0.00705 mol/l
Class : Soluble
Log S (Ali) : -2.01
Solubility : 1.89 mg/ml ; 0.00972 mol/l
Class : Soluble
Log S (SILICOS-IT) : -1.98
Solubility : 2.04 mg/ml ; 0.0105 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.79

Safety of [ 5198-86-7 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 5198-86-7 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 5198-86-7 ]
  • Downstream synthetic route of [ 5198-86-7 ]

[ 5198-86-7 ] Synthesis Path-Upstream   1~4

  • 1
  • [ 100367-77-9 ]
  • [ 5198-86-7 ]
YieldReaction ConditionsOperation in experiment
95% With sodium tetrahydroborate; water; lithium chloride In tetrahydrofuran for 2 h; Preparation of (2-bromothiazol-4-yl)methanol (5)
To a solution of ester 4 (10.0 g, 42.4 mmol, 1 equiv) in THF (200 mL) was added NaBH4 (4.81 g, 127 mmol, 3 equiv), LiCl (5.4 g, 130 mmol, 3 equiv) and H2O (40 mL). The resulting biphasic mixture was vigorously stirred for 2 h, after which TLC (20percent EtOAc:hexanes) showed complete consumption of starting material. The reaction was quenched with saturated aqueous NH4Cl (200 mL), diluted with EtOAc (200 mL), and the layers were separated. The aqueous layer was extracted with EtOAc (100 mL), and the organic layers were combined, dried (Na2SO4), filtered, and concentrated under reduced pressure to give the title compound as a yellow semi-solid (7.82 g, 95percent). Rf= 0.2 (SiO2, 20percent EtOAcrhexanes); 1H and 13C NMR of the product matched those previously reported (Wipf and Wang 2007).
91% at 20 - 70℃; for 8 h; 2-Bromothiazol-4-Carboxylic acid ethyl ester (11.8g, 50.0mmol)Was dissolved in absolute ethanol (100 mL)Sodium borohydride (3.8 g, 100 mmol) was added, stirred at room temperature for 4 hours, and then heated to 70 ° C for 4 hours.The solvent was evaporated under reduced pressure and the crude product was purified by column chromatography (ethyl acetate / petroleum ether (v / v) = 1/5) to give a pale yellow oil (8.85 g, 91percent).
87% With sodium tetrahydroborate In ethanol at 0 - 70℃; for 7.5 h; At 0 , 2-bromo-thiazole-4-carboxylate (13.30g, 56.33mmol)In ethanol (150 mL) was added portionwiseSodium borohydride (4.263 g, 112.7 mmol),Stirring was continued at 0 0.5 hours.The mixture was stirred at room temperature for 3 hours,And heated to 70 ° C for 4 hours.The solvent was distilled off under reduced pressure,Slowly add water (100 mL)Extracted with ethyl acetate (100 mL x 3).Combine organic phase,Washed with saturated brine (50 mL)Dried over anhydrous sodium sulfate.Filtration, evaporation of the solvent under reduced pressure,The crude product was purified by column chromatography (petroleum ether / ethyl acetate (v / v) = 5/1)To give a colorless oil (9.5 g, 87percent).
87% With sodium tetrahydroborate In ethanol at 0 - 20℃; for 3 h; Into a 500-mL round-bottom flask, was placed ethyl 2-bromothiazole-4-carboxylate (14 g, 59.30 mmol) and EtOH (200 mL). This was followed by the addition of NaBH4 (2.3 g, 60.53 mmol) in portions at 0oC. The resulting solution was stirred for 3 h at RT and then was quenched by the addition of 100 mL of water. The resulting solution was extracted with 2x200 mL of DCM and the organic layers combined and dried over anhydrous Na2SO4, then concentrated under vacuum. This resulted in 10 g (87percent) of the title compound as colorless oil. MS-ESI: 195.9, 193.9 (M+1).
68% With sodium tetrahydroborate; lithium chloride In tetrahydrofuran; water at 0 - 20℃; for 16 h; NaBH4 (2.49 g, 0.066 mol, 3 equiv), LiCl (2.79 g, 0.066 mol, 3 equiv) and H20 (30 mL) were added to a stirred solution ethyl 2-bromothiazole-4-carboxylate (1) (5.0 g, 0.022 mol, 1 equiv) in THF (50 mL) at 0 °C. The reaction mixture was allowed to warm to ambient temperature and stirred for 16 h. The reaction mixture was quenched with 1.5 M hydrochloric acid and the resulting mixture was extracted with ethyl acetate (2X150 mL). The combined organic layers were washed with water (150 mL), brine (150 mL), dried over Na2S04, filtered through celite bed and concentrated to provide compound 2 as a pale brown liquid (3.0 g, 68percent). LC-MS (ESI+): m/z 195.9 (M+H)+ 1H-NMR (300 MHz, DMSO-d6): δ 7.48 (s, 1H), 5.43 (t, J = 5.7 Hz, 1H), 4.52 (d, J = 5.7 Hz, 2H).
67%
Stage #1: With lithium borohydride In tetrahydrofuran for 1 h; Cooling with an ice bath
Stage #2: With methanol In tetrahydrofuran for 3.5 h;
Step 3 : (2-bromothiazol-4-yl)methanolA solution of ethyl 2-bromothiazole-4-carboxylate (7.821 g, 33.13 mmol) in THF (100 mL) was cooled in an ice-bath and treated portionwise with lithium borohydride (1.083 g, 49.70 mmol). After 1 hour MeOH (1.614 g, 2.040 mL, 50.36 mmol) was added over a period of half an hour. The reaction was allowed to stir for 3 hours and then the solvent was concentrated in vacuo and the resultant residue was dissolved in EtOAc, washed with HCl (2x), saturated sodium bicarbonate, followed by brine, dried (Na2SO4), concentrated and purified by column chromatography (EtOAc/Petroleum ether 1: 1) to give the required product as a colorless oil (4.3Og, 67percent Yield). 1H NMR (CDCl3, 400 MHz) δ 2.51 (IH, m), 4.75 (2H, m), 7.19 (IH, s); MS (ES+) 195.96

Reference: [1] Patent: WO2015/57585, 2015, A1, . Location in patent: Page/Page column 27; 28
[2] Patent: CN104478866, 2017, B, . Location in patent: Paragraph 0281; 0283; 0284
[3] Patent: CN104478869, 2017, B, . Location in patent: Paragraph 0142; 0143; 0144; 0145
[4] Patent: WO2017/184624, 2017, A1, . Location in patent: Page/Page column 185; 186
[5] Journal of Organic Chemistry, 2016, vol. 81, # 21, p. 10302 - 10320
[6] Russian Journal of General Chemistry, 2017, vol. 87, # 12, p. 2766 - 2775[7] Zh. Obshch. Khim., 2017, vol. 87, # 12, p. 1947 - 1956,10
[8] Organic Letters, 2007, vol. 9, # 8, p. 1605 - 1607
[9] Patent: WO2018/200674, 2018, A1, . Location in patent: Page/Page column 72
[10] Patent: WO2010/129668, 2010, A1, . Location in patent: Page/Page column 48
[11] Journal of Medicinal Chemistry, 2008, vol. 51, # 6, p. 1530 - 1533
[12] Bioorganic and Medicinal Chemistry Letters, 2015, vol. 25, # 22, p. 5172 - 5177
[13] Organic Process Research and Development, 2017, vol. 21, # 10, p. 1602 - 1609
  • 2
  • [ 170235-26-4 ]
  • [ 5198-86-7 ]
YieldReaction ConditionsOperation in experiment
49% at 0 - 90℃; for 1.33 h; Inert atmosphere A solution of methyl 2-bromothiazole-4-carboxylate (0.500 g, 2.25 mmol) in EtOH (10 mL) in a 50 mL flask under a nitrogen atmosphere was cooled to 0 °C and treated with NaBH4 (170 mg, 4.50 mmol) portion- wise over 5 min. After stirring for 15 min at 0 °C, the reaction mixture was heated at 90 °C for 1 h. The cooled mixture was then quenched with saturated aqueous NH4C1 (15 mL) and stirring was continued for 20 min. Ethyl acetate (50 mL) was then added and the organic phase was separated, washed with brine, dried over MgS04 and concentrated to give the title compound (0.212 g, 49percent) which was used as such in the next step. 1H NMR (CDCl3, 400 MHz) δ ppm: 7.18 (s, 1H), 4.76 (s, 2H), 2.21 (br s, 1H).
Reference: [1] Patent: WO2013/163279, 2013, A1, . Location in patent: Paragraph 00177
[2] Patent: WO2016/138199, 2016, A1, . Location in patent: Paragraph 0084
  • 3
  • [ 5198-80-1 ]
  • [ 5198-86-7 ]
Reference: [1] Patent: WO2008/57336, 2008, A2, . Location in patent: Page/Page column 39
  • 4
  • [ 5198-86-7 ]
  • [ 5198-80-1 ]
YieldReaction ConditionsOperation in experiment
92% With oxalyl dichloride; dimethyl sulfoxide; triethylamine In dichloromethane at -75 - 10℃; for 3 h; A solution of 0.22 mol of dimethyl sulfoxide in 50 mL of dichloromethane was added dropwise to a solution of 0.11 mol of oxalyl chloride in 200 mL of dichloromethane in a temperature range of –75 to –65°C. The mixture was stirred for 0.5 h, and then a solution of 0.1 mol of 11 in 100 mL of dichloromethane was added dropwise at –75 to –65°C. The mixture was stirred for an additional 2 h, and then 0.5 mol of triethylamine was added dropwise at –75 to –65°C. After the temperature of the reaction mixture was raised to –10°C for 1 h, the mixture was poured into a solution of 0.4 mol of sodium bicarbonate in 400 mL of water, stirred for 0.5 h and extracted with dichloromethane. The organic layer was dried with sodium sulfate, the solvent was removed at a reduced pressure, and the residue was chromatographed.
81% With Dess-Martin periodane In dichloromethane at 20℃; for 2 h; Into a 250-mL round-bottom flask, was placed (2-bromothiazol-4-yl)methanol (10 g, 51.53 mmol), DCM (100 mL) and Dess-Martin reagent (24 g, 56.60 mmol). The resulting solution was stirred for 2 h at RT and then was concentrated under vacuum. The residue was applied onto a silica gel column and eluted with ethyl acetate/petroleum ether (1:50 to 1:20). This resulted in 8 g (81percent) of the title compound as yellow oil. MS-ESI: 193.9, 191.9 (M+1).
Reference: [1] Russian Journal of General Chemistry, 2017, vol. 87, # 12, p. 2766 - 2775[2] Zh. Obshch. Khim., 2017, vol. 87, # 12, p. 1947 - 1956,10
[3] Patent: WO2017/184624, 2017, A1, . Location in patent: Page/Page column 185; 186
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 5198-86-7 ]

Bromides

Chemical Structure| 7238-61-1

[ 7238-61-1 ]

2-Bromo-4-methylthiazole

Similarity: 0.84

Chemical Structure| 5198-88-9

[ 5198-88-9 ]

2-Bromothiazole-4-carboxylic acid

Similarity: 0.84

Chemical Structure| 170235-26-4

[ 170235-26-4 ]

Methyl 2-bromothiazole-4-carboxylate

Similarity: 0.77

Chemical Structure| 848501-90-6

[ 848501-90-6 ]

2-Bromo-4-cyanothiazole

Similarity: 0.75

Chemical Structure| 100367-77-9

[ 100367-77-9 ]

Ethyl 2-bromothiazole-4-carboxylate

Similarity: 0.75

Alcohols

Chemical Structure| 7036-04-6

[ 7036-04-6 ]

4-(Hydroxymethyl)thiazole

Similarity: 0.80

Chemical Structure| 51307-43-8

[ 51307-43-8 ]

(2-Aminothiazol-4-yl)methanol

Similarity: 0.68

Chemical Structure| 496062-16-9

[ 496062-16-9 ]

2-Bromo-4-(2-hydroxyethyl)-5-methylthiazole

Similarity: 0.66

Chemical Structure| 687636-93-7

[ 687636-93-7 ]

2-Bromothiazole-5-methanol

Similarity: 0.62

Chemical Structure| 170232-68-5

[ 170232-68-5 ]

2,4-Dibromothiazole-5-methanol

Similarity: 0.56

Related Parent Nucleus of
[ 5198-86-7 ]

Thiazoles

Chemical Structure| 7238-61-1

[ 7238-61-1 ]

2-Bromo-4-methylthiazole

Similarity: 0.84

Chemical Structure| 5198-88-9

[ 5198-88-9 ]

2-Bromothiazole-4-carboxylic acid

Similarity: 0.84

Chemical Structure| 7036-04-6

[ 7036-04-6 ]

4-(Hydroxymethyl)thiazole

Similarity: 0.80

Chemical Structure| 170235-26-4

[ 170235-26-4 ]

Methyl 2-bromothiazole-4-carboxylate

Similarity: 0.77

Chemical Structure| 848501-90-6

[ 848501-90-6 ]

2-Bromo-4-cyanothiazole

Similarity: 0.75